Bayer and BioNTech Join Forces to Develop Innovative New mRNA Vaccines and Therapeutics for Animal Health Applications
	
	
	
		
				Leverkusen / Mainz, Germany, May 10, 2016 - Bayer and BioNTech AG, a leading immunotherapy company headquartered in Mainz, Germany have entered into an…
			
		Read more